$Anavex Life Sciences(AVXL.US)$Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans
$Anavex Life Sciences(AVXL.US)$Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia 2 MINUTES AGO, 7:30 AM EST VIA GLOBENEWSWIRE
Anavex Life Sciences股票讨论区
Update
Update
Interesting, very very interesting. 👀
暂无评论